News

Published on 5 Mar 2024 on Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday’s...


Article preview image

Shares of SOPHiA GENETICS SA SOPH fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company’s quarterly sales came in at $17.05 million, missing estimates of $17.33 million.

NASDAQ.SPT price evolution
NASDAQ.EBTC price evolution
NYSE.RBOT price evolution
NYSE.ELF price evolution
NASDAQ.PHUN price evolution
NYSE.ALB price evolution
NASDAQ.RNLX price evolution
NYSE.SEMR price evolution
NASDAQ.CARA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report

As you might know, Cara Therapeutics, Inc. (NASDAQ:CARA) last week released its latest full-year,...

Simply Wall St. via Yahoo Finance 6 Mar 2024

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday’s...

Shares of SOPHiA GENETICS SA SOPH fell sharply during Tuesday’s session after the company report...

Benzinga 5 Mar 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therape...

Insider Monkey via Yahoo Finance 5 Mar 2024

CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%

Cara Therapeutics, Inc. CARA, a commercial-stage company, announced the failure of its dose-findi...

Zacks via Yahoo Finance 19 Dec 2023

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript November 13, 2023 Cara The...

Insider Monkey via Yahoo Finance 14 Nov 2023

These Biotech Stocks Could Double Your Money, According To Analysts

The biotech industry has been in the limelight since the COVID-19 pandemic, with public and priva...

Benzinga via Yahoo Finance 9 Nov 2023

News Flash: Analysts Just Made A Substantial Upgrade To Their Cara Therapeutics, Inc. (NASDAQ:CARA)...

Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders will have a reason to smile today, with the an...

Simply Wall St. via Yahoo Finance 4 Nov 2023

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript August 7, 2023 Cara Therap...

Insider Monkey via Yahoo Finance 10 Aug 2023

The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. A...

Simply Wall St. via Yahoo Finance 22 Jun 2023

Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark

You may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc. (NASDAQ...

Simply Wall St. via Yahoo Finance 25 May 2023